# Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns

> **NCT00283426** · PHASE1 · TERMINATED · sponsor: **Biotec Pharmacon ASA** · enrollment: 10 (—)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Soluble beta-1,3/1,6-glucan

## Key facts

- **NCT ID:** NCT00283426
- **Lead sponsor:** Biotec Pharmacon ASA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 10 (—)
- **Why stopped:** Slow patient recruitment
- **Last updated:** 2007-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00283426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00283426, "Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00283426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*